Locally advanced tonsillar squamous cell carcinoma: Treatment approach revisited

Laryngoscope

Volumn 117, Issue 1, 2007, Pages 45-50

  Poulsen, Michael ^a,d   Porceddu, Sandro V ^b   Kingsley, Pamela Alice ^a   Tripcony, Lee ^c   Coman, William ^b  

^a Queensland Radium Institute   (Australia)

^b PRINCESS ALEXANDRA HOSPITAL   (Australia)

^c ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^d Southern Zone Radiation Oncology   (Australia)

Author keywords

Chemotherapy; Radiotherapy; Surgery; Tonsil carcinoma; Treatment

Indexed keywords

CISPLATIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; INOPERABLE CANCER; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; SURGICAL APPROACH; TONSIL CARCINOMA; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TONSILLAR NEOPLASMS;

EID: 33846037278     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mlg.0000243044.91193.32     Document Type: Article

References (20)

1. Parsons JT, Mendenhall WM, Stringer SP, et al. Squamous cell carcinoma of the oropharynx surgery, radiation therapy, or both. Cancer 2002;94:2967-2980.
2. Kramer S, Gelber R, Snow W, Marcial V, et al. Combined radiation therapy and surgery in the management of advanced head and neck cancer: final report of the Radiation Therapy Oncology Group. Head Neck Surg 1987;10:19-30.
3. TNM classification for malignant tumours. In: UICC, 6th ed. New York: John Wiley & Sons, 2002.
4. Lee WR, Mendenhall WM, Parsons JT, et al. Carcinoma of the tonsillar region: a multivariate analysis of 243 patients treated with radical radiotherapy. Head Neck 1993;15:283-288.
5. Calais G, Alfonsi M, Bardet E, et al. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst 1999;91:2081-2086.
6. Brizel DM, Albers ME, Fisher SR, et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Eng J Med 1998;338:1798-1804.
7. Adelstein DJ, Tan EH, Lavertu P. Treatment of head and neck cancer: the role of chemotherapy. Crit Rev Oncol Hematol 1996;24:97-116.
8. Horiot JC, LeFur R, N'Guyen T, et al. Hyperfractionated versus conventional fractionation in oropharyngeal carcinoma: the final analysis of the EORTC co-operative group of radiotherapy. Radio Oncol 1992;25:231-241.
9. Gluckman JL, Black RJ, Crissman JD. Cancer of the oropharynx. Otolaryngol Clin North Am 1985;18:451-459.
10. Zelefsky MJ, Harrison LB, Armstrong JG. Long-term treatment postoperative radiation therapy for advanced stage oropharyngeal carcinoma. Cancer 1992;70:2388-2395.
11. Foote RL, Hilgenfeld RU, Kunselman SJ, et al. Radiation therapy for squamous cell carcinoma of the tonsil. Mayo Clin Proc 1994;69:525-531.
12. Hicks WL, Kuriakose MA, Loree TR, et al. Surgery versus radiation therapy as single-modality treatment of tonsillar fossa carcinoma: the Roswell Park Cancer Institute experience (1971-1991). Laryngoscope 1998;108:1014-1019.
13. Givens CD Jr, Johns ME, Cantrell RW. Carcinoma of the tonsil. Analysis of 162 cases. Arch Otolaryngol 1981;107:730-734.
14. Rabuzzi DD, Mickler AS, Clutter DJ, Sagerman RH. Treatment results of combined high-dose preoperative radiotherapy and surgery for oropharyngeal cancer. Laryngoscope 1982;92:989-992.
15. Fayos JV, Morales P. Radiation therapy of carcinoma of the tonsillar region. Int J Radiat Oncol Biol Phys 1983;9:139-144.
16. Fu KK, Pajak TF, Trotti A, et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 2000;48:7-16.
17. Pinto LH, Nanry PC, Araujo CM, et al. Prospective randomised trial comparing hyperfractionated versus conventional radiotherapy in Stage III an IV oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1991;21:557-562.
18. Pignon J, Bourhis C, Domenge R, Designe L. Chemotherapy added to loco regional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-analysis of chemotherapy on head and neck cancer. Lancet 2000;355:949-955.
19. Rischin D, Peters L, Fisher R, et al. Tirapazamine, cisplatin, and radiation versus fluorouracil, cisplatin, and radiation in patients with locally advanced head and neck cancer: a Trans-Tasman Radiation Oncology Group (TROG 98.02). J Clin Oncol 2005;23:79-87.
20. Mendenhall W, Morris C, Andur R, et al. Definitive radiotherapy for tonsillar squamous cell carcinoma. Am J Clin Oncol 2006;29:290-297.